Betagan  (U.S.N.L.M.)
Dosing 0.5%:  1 or 2 drops qAM to start,  bid max.        0.25%:  1 or 2 drops bid.
Chem Specs levobunolol HCL  0.25%,  0.5%
Quantities 5, 10, 15ml (0.5%)     10, 15ml (0.25%)
Cost 24.75/5ml 0.5%    generic
Class Noncardioselective Beta-Blocker
Action Ocular hypotensive via decrease in aqueous humor production.
Usage Indicated for lowering IOP with chronic open-angle glaucoma or ocular hypertension.
Evaluate blood pressure, pulse, neurological and respiratory status before and
during treatment.
Evaluate blood pressure, pulse, neurological and respiratory status before and during treatment.
Contraindications Asthma, COPD, bradycardia and/or congestive heart failure, uncontrolled
diabetes and hyperlipidemia.
Asthma, COPD, bradycardia and/or congestive heart failure, uncontrolled diabetes and hyperlipidemia.
Pediatric use Safety and effectiveness in pediatric patients have not been established.
Pregnancy Category C. Fetotoxicity demonstrated in rabbits but not replicated in rats.
Longest half-life of the topical beta-blockers. Dosages above 1 drop 0.5%
bid are generally not more effective. Studies support 1 drop 0.25% qd for some.
0.004% BAK preserved.
Longest half-life of the topical beta-blockers. Dosages above 1 drop 0.5% bid are generally not more effective. Studies support 1 drop 0.25% qd for some. 0.004% BAK preserved.
    N.L.M. DailyMed page for Betagan         PDR page for Betagan